481 Results (Page 16 of 20)
Spain Markets Research Reports
Spain Hepatorenal Syndrome Therapeutics Market Analysis
Spain Hepatorenal Syndrome Therapeutics (HRS) Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. People with cirrhosis or acute liver failure who develop kidney impairment are said to have hepatorenal syndrome (HRS), a serious consequence of advanced liver disease. Renal function improvement and halting further decline are the main objectives of treatment for hepatorenal syndrome. The market for HRS Therapeutics is being driven by an increase in the number of patients with liver illnesses, ongoing medical technology breakthroughs, government efforts, and partnerships and collaborations amongst pharmaceutical companies. Ferring Pharmaceuticals, Hospira, Pfizer, Sandoz, Novartis, Grifols, CSL Behring, Octa pharma, and Baxalta are major international participants in the market for treatments for hepatocellular syndrome.
Spain Hereditary Angioedema Therapeutics Market Analysis
Spain Hereditary Angioedema Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. A uncommon genetic condition known as hereditary angioedema (HAE) is characterised by recurrent episodes of swelling in different body areas. It is brought on by a lack or malfunction of certain proteins involved in controlling the immune response. The regulatory authorities have designated numerous HAE therapies as orphan drugs as a result of this classification, pharmaceutical companies are given some incentives including financial advantages and prolonged exclusivity, which may promote investment in HAE R&D. The increasing prevalence and diagnosis of HAE around the world have been driving the growth of the global market for HAE therapies. This trend offers pharmaceutical businesses the chance to increase their market share, make research and development investments, and introduce novel treatments to various geographic areas. Hereditary angioedema therapies are being developed and produced by a number of international pharmaceutical companies (HAE). Takeda Pharmaceutical Company Limited, Inc., CSL Behring, Pharming Group NV, Ionis Pharmaceuticals, Pharvaris, Dyax Corp., Shire (now a part of Takeda), Attune Pharmaceuticals, Prometic Life Sciences Inc., KalVista Pharmaceuticals, and Biocryst are some of these organisations.
Spain Hodgkin Lymphoma Therapeutics Market Analysis
Spain Hodgkin Lymphoma Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. Hodgkin lymphoma is a type of cancer that originates from white blood cells called lymphocytes. Increasing incidence of Hodgkin lymphoma, Extensive research and development activities, Growing adoption of immunotherapies, Improved reimbursement policies and increased insurance coverage for cancer treatments along with growing awareness are drivers for Hodgkin Lymphoma Therapeutics Market. Bristol Myers Squibb, Merck & Co., Inc. (MSD), Takeda Pharmaceutical Company Limited, Roche Holding AG, Novartis AG, Pfizer Inc., AstraZeneca plc, Johnson & Johnson, AbbVie Inc., Celgene Corporation (a subsidiary of Bristol Myers Squibb), Amgen Inc., Gilead Sciences, Inc. are the global companies in Hodgkin lymphoma therapeutics market.
Spain Hunter Syndrome Therapeutics Market Analysis
Spain Hunter Syndrome Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. Rare X-linked recessive genetic disorder MPS II (Hunter Syndrome) is brought on by changes in the iduronate-2-sulfatase gene (IDS). Due to the poor understanding of the illness, creating effective treatments for uncommon diseases can be difficult and expensive, which has a negative impact on the market for syndromes. Global Key Players in the Hunter Syndrome Therapeutics Market Include Takeda Pharmaceutical Company Limited, BioMarin Pharmaceutical Inc., Shire (now a part of Takeda), Sanofi Genzyme, Ultragenyx Pharmaceutical Inc., Sangamo Therapeutics, Inc., RegenxBio Inc., Denali Therapeutics Inc., JCR Pharmaceuticals Co., Ltd., and ArmaGen Inc.
Spain Huntington's Disease Therapeutics Market Analysis
Spain huntington's disease therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The market for treating Huntington's disease is expanding due to a number of causes, including an increase in the disease's prevalence and a rise in the demand for modern drug types to treat the signs and symptoms of the disease. Some of the key players in the global Huntington's Disease Therapeutics Market include Pfizer, Inc. Alnylam Pharmaceuticals Inc. Teva Pharmaceutical Industries Ltd. Neurocrine Biosciences, Inc. Ionis Pharmaceuticals,Vertex Pharmaceuticals Incorporated (U.S.), Elekta AB (Sweden), Alterity Therapeutics (Australia) and som biotech (spain).
Spain Hyperhidrosis Therapeutics Market Analysis
Spain hyperhidrosis therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. The increase in disease incidence, particularly axillary hyperhidrosis in industrialised nations, is one of the causes driving the market for hyperhidrosis treatments. Additionally, it is projected that increasing healthcare service demand will considerably fuel market growth, along with an increase in new product releases and product approvals.The global hyperhidrosis treatment market?s major key players are AbbVie Inc. (Allergan PLC), Brickell Biotech Inc., Eli Lilly and Company (Dermira), 1315 Capital (miraDry Inc.), SweatBlock, Merz Pharma (Merz Aesthetics), Dermavant Sciences Inc. (Roivant Sciences), Advin Health Care, Dermadry Laboratories Inc., and Dermata Therapeutics Inc
Spain eHealth Market Analysis
This report presents a strategic analysis of the Spain eHealth Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Spain eHealth Market, offering unmatched value, accuracy and expert insights.
Spain Diabetes Therapeutics Market Analysis
Spain's diabetes therapeutics market is expected to grow from $2.77 Bn in 2022 to $5.41 Bn in 2030 with a CAGR of 8.7% for the forecasted year 2022-2030. The increasing prevalence of diabetes and the supportive government policies to promote diabetes-related research and development projects are responsible for the expansion of the market. The Spain diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Farmalider, Cenfarte, and Boehringer Ingelheim are the major players in the Spain diabetes therapeutics market.
Spain Dermatology Drugs Market Analysis
By 2030, it is anticipated that the Spain Dermatology drugs market will reach a value of $693.15 Mn from $328.1 Mn in 2022, growing at a CAGR of 9.8% during 2022-2030. The market is primarily dominated by local players such as Infarco, Cantabria Labs, and Almirall. The market is driven by hefty manufacturing and development costs, increasing prevalence, and good health insurance. The dermatology drug market in Spain is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
Spain Teleradiology Market Analysis
Spain's Teleradiology market size was valued at $46 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 10.7% from 2022 to 2030 and will reach $ 103 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. Teleradiology is becoming increasingly popular in Spain due to the growing demand for remote healthcare services, particularly in rural or underserved areas. The key market players are Radiber, Teleradiología de España, Medicasur, Hospital Clínic de Barcelona, and Telerradand others.
Spain Telemedicine Market Analysis
This report presents a strategic analysis of the Spain Telemedicine Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Spain Telemedicine Market, offering unmatched value, accuracy and expert insights.
Spain Home Healthcare Market Analysis
Spain's home healthcare market was valued at $6.99 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.93% from 2022 to 2030 and will reach $11.96 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, The increased prevalence of chronic ailments. The market is segmented by equipment and by services. Some key players in this market are Cuideo, Yocuido, Angels Nursing Care, Medifiatc, and Sanitas.
Spain Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
Spain's Chronic Obstructive Pulmonary Disease (COPD) therapeutics market was valued at $352 Mn in 2022 and is estimated to expand at a CAGR of 6.1% from 2022 to 2030 and will reach $566 Mn in 2030. One of the main reasons propelling the growth of this market is the ageing population and government initiatives. The market is segmented by drug class and by distribution channel. Some key players in this market are Bioiberica, Ferrer, Laboratorios Esteve, Chiesi España, Almirall, Astellas Pharma, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, Teva Spain Limited and others.
Spain Oncology Clinical Trials Market Analysis
Spain's oncology clinical trials market is projected to grow from $244.1 Mn in 2022 to $347.2 Mn by 2030, registering a CAGR of 4.5% during the forecast period of 2022-30. The market will be driven by the rising frequency of cancer in the population and the country's well-developed clinical research infrastructure. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, FHoffmann-La Roche Ltd & Grifols.
Spain Dialysis Market Analysis
Spain's Dialysis Market is projected to grow from $2.243 Bn in 2022 to $ Bn by 2030, registering a CAGR of 6% during the forecast period of 2022-2030. The increasing incidence of CKD in Spain is another key driver of the dialysis market. CKD is a leading cause of end-stage renal disease (ESRD), which requires dialysis or kidney transplantation. Some key players in the Spain dialysis market include Fresenius Medical Care, Nipro Medical Corporation, and Diaverum.
Spain Artificial Intelligence (AI) in Healthcare Market Analysis
Spain's Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.13 Bn in 2022 to $2.49 Bn by 2030, registering a CAGR of 44.22% during the forecast period of 2022-2030. The market will be driven by the government's support and increasing industry collaborations. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Methinks & IOMED.
Spain Retail Pharmacy Market Analysis
Spain's retail pharmacy market is projected to grow from $20.05 Bn in 2022 to $31.70 Bn by 2030, registering a CAGR of 5.9% during the forecast period of 2022-2030. The retail pharmacy market in Spain is a well-established market, with over 24,000 pharmacies operating in the country. Farmacias Ahorro is a top retail pharmacy chain in Spain with more than 1,000 stores in the country.
Spain Electronic Records Management Solutions Market Analysis
Spain's electronic records management solutions market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by solution and deployment. Spain’s Electronic Records Management Solutions market will grow as a growing number of firms are aiming to digitize their record management systems in order to increase productivity, cut costs, and enhance security. The key market players are IBM Corporation, OpenText Corporation, Microsoft Corporation, Oracle Corporation, Hyland Software, Inc, and others.
Spain Biosimilars Market Analysis
Spain's biosimilars market size was valued at $0.4 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 21.1% from 2022 to 2030 and will reach $1.7 Bn in 2030. The market is segmented by product type and indication type. The Spainn Biosimilars market will grow as there is a shortage of qualified radiologists and imaging technologists in some areas, leading to longer wait times and delays in diagnosis and treatment. The key market players are Pfizer (USA), Roche (CHE), Novartis (CHE), Merck (USA), Sanofi (FRA), GlaxoSmithKline (GBR), AstraZeneca (GBR), and others.
Spain 3D Imaging Market Analysis
Spain's 3D Imaging market is projected to grow from $0.59 Bn in 2022 to $1.86 Bn by 2030, registering a CAGR of 15.5% during the forecast period of 2022-30. The market will be driven by the increase in outpatient diagnostic services and the rise in minimally invasive surgical techniques. The market is segmented by product, by application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Philips Healthcare.
Spain Depression Therapeutics Market Analysis
The Spain depression therapeutics market is expected to witness growth from $195 Mn in 2022 to $271 Mn in 2030 with a CAGR of 4.2% for the forecasted year 2022-2030. The increasing incidence of depression in Spain and rising healthcare expenditure are the major growth drivers of the market. The Spain depression therapeutics market is segmented by drug type, therapies, indication, and by end users. TecnyFarma, Pharmaloop, and Pfizer are the major players in the Spain depression therapeutics market.
Spain Biomaterials in Healthcare Market Analysis
The Spain Biomaterials Healthcare Market is expected to witness growth from $3.01 Bn in 2022 to $7.57 Bn in 2030 with a CAGR of 12.20% for the forecasted year 2022-2030. In Spain, Biomaterials are used in the developing area of regenerative medicine to repair or replace diseased or damaged tissues and organs. This is fuelling demand for biomaterials in Spain's healthcare market. The market is segmented by type and by application. Some key players in this market include Bioiberica, Regemat, Quimatryx, BASF SE, Celanese, Covestro AG and Evonik Industries.
Spain Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Spain Lung Cancer Therapeutics Market will reach a value of $996 Mn from $575 Mn in 2022, growing at a CAGR of 7.1% during 2022-2030. The Lung Cancer Therapeutics Market in Spain is dominated by a few domestic pharmaceutical companies such as Grifols, PharmaMar, and Almirall. The Lung Cancer Therapeutics Market in Spain is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Spain lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Spain Cardiovascular Diseases Therapeutics Market Analysis
Spain's cardiovascular disease therapeutics market is expected to witness growth from $3.13 Bn in 2022 to $5.08 Bn in 2030 with a CAGR of 6.22% for the year 2022-2030. People in Spain are becoming more aware of cardiovascular diseases and their implications, therefore, leading to the development of new and inventive therapeutic options for the treatment of cardiovascular disease in Spain. The Spain cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Pharmagenus, Ferrer, and Janssen Pharmaceuticals are the major players in the Spain cardiovascular disease therapeutics market.
Spain Diabetes Devices Market Analysis
The Spain Diabetes Devices Market is expected to witness growth from $439 Mn in 2022 to $710 Mn in 2030 with a CAGR of 6.20% for the forecasted year 2022-2030. In Spain, diabetes instances have been steadily increasing in recent years. This tendency, which is anticipated to continue, will lead to an increase in the market for diabetes devices. The market is segmented by type and by the end user. Some key players in this market include Medlumics, Ekuore, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.